ORPHA:90081
AIDS wasting syndrome
- Type
- Particular clinical situation in a disease or syndrome
- Group
- Disorder
- Inheritance
- Not applicable
- Age of onset
- All ages
- Status
- active
A rare condition associated with acquired immunodeficiency syndrome (AIDS) and characterized by unwanted weight loss (involving both fat and muscle) of more than ten percent of body weight, with either diarrhea or weakness and fever which have lasted at least 30 days and are not related to an infection.
1
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | AIDS wasting syndrome | |
| fr | Etat de cachexie lié au sida | |
| de | Wasting-Syndrom bei AIDS | HIV-Auszehrungssyndrom |
| es | Síndrome de desgaste asociado al SIDA | |
| it | Sindrome da deperimento da AIDS | |
| nl | AIDS-cachexiesyndroom | |
| pt | Síndrome de caquexia associada à SIDA | |
| pl | Zespół wyniszczenia wywołany AIDS | |
| cs | AIDS syndrom chřadnutí | |
| uk | Синдром виснаження при СНІДі | |
| zh | 艾滋病消耗综合征 | |
| tr | AIDS tükenmişlik sendromu |
Definition in:
2
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| ICD-10 | B22.2 | E | specific | validated |
| ICD-11 | 1C62.3Y | NTBT | index | validated |
| MONDO | 0005797 | E | validated | |
| MONDO | 5797 | E | validated | |
| MeSH | D019247 | E | validated | |
| UMLS | C0343755 | E | validated | |
| MedDRA | 10050309 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
3
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:310050Rare acquired immunodeficiency
rare immunological diseases
No children.
4
Genes
0 directOrphanet records no gene directly on this code.
5
Prevalence and incidence
1 record| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Point prevalence | 1-5 / 10 000 | 20 / 100 000 | Europe | Value and class | Validated | European Medicines Agency[OTHER] |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
6
HPO phenotypes
8 annotations · validated 2023-08-25| HPO | Term (as annotated by Orphanet) | Diagnostic |
|---|---|---|
| Frequent (79-30%) | ||
| HP:0500012 | Abnormal gonadotropin-releasing hormone concentration | |
| HP:0002039 | Anorexia | |
| HP:0004326 | Cachexia | |
| HP:0002721 | Immunodeficiency | |
| HP:0002024 | Malabsorption | |
| HP:0004395 | Malnutrition | |
| HP:0003202 | Skeletal muscle atrophy | |
| HP:0001824 | Weight loss | |
Annotation source: 9834931[PMID]
7
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/90081
- This record as JSON: /data/d/90081.json